Ajanta Pharma board to review Q2, half-year financials on November 3

Ajanta Pharma has announced that its board of directors will meet on Monday, November 3, 2025. The primary agenda for this meeting is to consider and approve the unaudited consolidated and standalone financial results of the company for the second quarter and the half-year period ended September 30, 2025.

This intimation was made under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was signed by gaurang shah, senior vice president – legal & company secretary, and dated October 8, 2025.